Picture of Gentian Diagnostics ASA logo

GENT Gentian Diagnostics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapFalling Star

Brief: Gentian Diagnostics Q2 EBITDA At NOK 6.8 Mln

Aug 29 (Reuters) - GENTIAN DIAGNOSTICS ASA  GENT.OL :
    * SALES OF NOK 38.3 MILLION IN 2Q24, UP 12% VERSUS 2Q23 (13%
ORGANIC GROWTH). REVENUE
    * EBITDA OF NOK 6.8 MILLION IN 2Q24 VERSUS NOK 3.6 MILLION
IN
2Q23.
    * REVENUE OF NOK 76.8 MILLION IN 1H24 UP 17% VERSUS 1H23
(16%
ORGANIC GROWTH)
    * EBITDA OF NOK 11.6 MILLION IN 1H24 VERSUS NOK 3.1 MILLION
IN
1H23

Source text for Eikon:  ID:nObiY1vkwa 
Further company coverage:  GENT.OL 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Gentian Diagnostics ASA

See all news